News | December 20, 2011

Medical Centers Worldwide Adopting Accuray’s CyberKnife, TomoTherapy Systems

December 20, 2011 — Accuray announced that 23 leading medical centers globally have installed both a CyberKnife Robotic Radiosurgery System  and a TomoTherapy System. Combining the two systems will enable the delivery of personalized treatment for the full spectrum of radiation oncology patients.

These centers include smaller community sites in rural areas, mid-sized regional hospitals and large academic centers, indicating that centers of all sizes can benefit from these devices.

"We now have the ability to design treatments that fit the individual needs of all patients," said Sandra Vermuelen, M.D., executive medical director of the Swedish Radiosurgery Center in Seattle. "The CyberKnife and TomoTherapy systems are designed to allow clinicians to create specialized treatments with the ability to facilitate a complete range of treatment techniques ranging from static 3-D conformal and highly modulated intensity-modulated radiotherapy (IMRT), to stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS). Through the use of daily image-guidance, a standard feature for TomoTherapy, and the CyberKnife system's ability to track, detect and automatically correct for tumor and patient movement, we can ensure the most accurate treatment delivery for all patients."

More than half the centers with both systems are in North America including St. John Medical Center in Tulsa, Centre Hospitalier de l'Universite in Montreal (CHUM) and Swedish Medical Center in Seattle. Recent centers in other nations that now have both systems installed and treating patients include Tokyo's Metropolitan Center and Infectious Diseases Center Komagome Hospital and Italy's Istituto Europeo di Oncologia.

For more information: www.accuray.com

 

 

Related Content

IBA Releases Razor Nano Ionization Chamber
News | Proton Therapy | September 22, 2017
September 22, 2017 — IBA (Ion Beam Applications S.A.) announced the release of the Razor Nano Chamber, the smallest a
Penn Medicine Treats World's First Patient on Varian's Halcyon System
News | Radiation Therapy | September 22, 2017
September 22, 2017 — Varian Medical Systems announced a patient at Penn Medicine, with head & neck cancer, became
BrainLAB Announces FDA Clearance For Two New Indication-Specific Radiosurgery Software Applications
Technology | Treatment Planning | September 21, 2017
Brainlab announced that it has received U.S. Food and Drug Administration (FDA) clearance for Elements Spine SRS and...
Accuray Showcases CyberKnife and Radixact Systems at ASTRO 2017
News | Radiation Therapy | September 21, 2017
Accuray Inc. announced that data and first-hand experience with its advanced CyberKnife and Radixact Systems will be...
RayCare Oncology Information System Being Shown at ASTRO 2017
News | Radiation Therapy | September 20, 2017
RaySearch will be exhibiting its next-generation oncology information system (OIS) RayCare, among other highlights, at...
ProCure Proton Therapy Center New Jersey Celebrates Five-Year Cancer-Free Milestone for Prostate Cancer Patients
News | Proton Therapy | September 20, 2017
ProCure Proton Therapy Center in Somerset, N.J., recently celebrated the five-year cancer-free milestone for the first...
Varian to Showcase Latest Radiation Therapy Technologies and Software at ASTRO 2017
News | Radiation Therapy | September 19, 2017
Varian Medical Systems announced it will be demonstrating its new Halcyon platform and HyperArc high-definition...
Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting
News | Radiation Therapy | September 19, 2017
September 19, 2017 — Elekta will highlight its Mosaiq Oncology...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Overlay Init